Dynamic Technology Lab Private LTD Affimed N.V. Transaction History

Dynamic Technology Lab Private LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.1 - $2.45 $90,626 - $201,850	82,388 New	82,388 $102,000
Q2 2022 Aug 12, 2022	BUY	$2.27 - $4.86 $26,084 - $55,846	11,491 Added 56.9%	31,687 $88,000
Q1 2022 May 16, 2022	SELL	$3.69 - $5.65 $6,955 - $10,650	-1,885 Reduced 8.54%	20,196 $88,000
Q4 2021 Feb 14, 2022	BUY	$5.37 - $7.07 $118,574 - $156,112	22,081 New	22,081 $122,000
Q3 2021 Nov 15, 2021	SELL	$5.54 - $7.51 $98,323 - $133,287	-17,748 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$7.78 - $11.4 $138,079 - $202,327	17,748 New	17,748 $150,000
Q4 2020 Feb 11, 2021	SELL	$3.16 - $7.03 $75,530 - $168,031	-23,902 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.26 - $4.73 $77,920 - $113,056	23,902 New	23,902 $81,000
Q1 2020 May 13, 2020	SELL	$1.44 - $3.02 $16,580 - $34,772	-11,514 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.25 - $3.07 $25,906 - $35,347	11,514 New	11,514 $32,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $154M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.